Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 9/20 | 0.49 |
| ▸ | AKR1C2 | P52895 | 9/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.46 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | PRKCI | P41743 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | S100A4 | P26447 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29361599 | 1.00 | AKR1C3 (0.49) | AKR1C3AKR1C2MAPTRAB9ANPC1 | |
| SCHEMBL16261358 | 0.89 | AKR1C3 (0.57) | AKR1C3AKR1C2AKR1B10AKR1B1AKR1C4 | |
| SCHEMBL4623376 | 0.89 | AKR1C3 (0.57) | AKR1C3AKR1C2AKR1B10AKR1B1AKR1C4 | |
| SCHEMBL10046615 | 0.88 | L3MBTL1 (0.48) | AKR1C3AKR1C2MAPTHPGDLMNA | |
| SCHEMBL7898447 | 0.86 | KDM4E (0.52) | AKR1C3AKR1C2MAPTRAB9AAKR1B10 | |
| SCHEMBL10802946 | 0.84 | PARP1 (0.45) | KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL4623645 | 0.84 | MAPT (0.40) | AKR1C3AKR1C2MAPTRAB9ANPC1 | |
| SCHEMBL21729726 | 0.83 | KDM4E (0.44) | AKR1C3AKR1C2MAPTRAB9ANPC1 | |
| SCHEMBL22548736 | 0.83 | KDM4E (0.44) | AKR1C3AKR1C2MAPTRAB9ANPC1 | |
| SCHEMBL17281008 | 0.82 | AKR1C3 (0.37) | AKR1C3AKR1C2MAPTRAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 342 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3861039-B1 | HYDROGEL COMPOSITIONS | OPHTALMIC CIE (FR) | 2023-11-01 | — | — | EP | claimed |
| US-20210332174-A1 | HYDROGEL COMPOSITIONS | OPHTALMIC COMPAGNIE (FR) | 2021-10-28 | — | — | US | claimed |
| EP-3861039-A1 | HYDROGEL COMPOSITIONS | Ophtalmic Compagnie (FR) | 2021-08-11 | — | — | EP | claimed |
| CN-113166340-A | Hydrogel composition | 眼科公司 | 2021-07-23 | — | — | CN | claimed |
| WO-2020070423-A1 | HYDROGEL COMPOSITIONS | OPHTALMIC COMPAGNIE (FR) | 2020-04-09 | — | — | WO | claimed |
| CN-107326393-B | A kind of preparation method of water power parsing oxygen non-precious metal catalyst | 广西大学 | 2019-08-23 | — | — | CN | claimed |
| US-20110123721-A1 | ENZYMATIC SYNTHESIS OF POLYOL ACRYLATES | BASF AKTIENGESELLSCHAFT (DE) | 2011-05-26 | — | — | US | claimed |
| US-12559631-B2 | Thermally curable two-component coating compounds | BASF SE (DE) | 2026-02-24 | — | — | US | disclosed |
| US-20250368830-A1 | METHOD FOR TRANSFERRING AN EMBOSSED STRUCTURE TO THE SURFACE OF A COATING, AND COMPOSITE EMPLOYABLE AS EMBOSSING MOLD | BASF COATINGS GMBH (DE) | 2025-12-04 | — | — | US | disclosed |
| EP-3094493-B2 | LAYERED BUILDING BOARD FOR INSIDE AND OUTSIDE | KRONOPLUS TECHNICAL AG (CH) | 2025-09-03 | — | — | EP | disclosed |
| US-12386253-B2 | Method for transferring an embossed structure to the surface of a coating, and composite employable as embossing mold | BASF COATINGS GMBH (DE) | 2025-08-12 | — | — | US | disclosed |
| US-20250215122-A1 | CURABLE COMPOSITION FOR 3D PRINTING PROCESS AND 3D-PRINTED OBJECT FORMED THEREFROM AND 3D PRINTING PROCESS USING THE SAME | BASF SE (DE) | 2025-07-03 | — | — | US | disclosed |
| US-20250178271-A1 | METHOD FOR TRANSFERRING AN EMBOSSED STRUCTURE TO THE SURFACE OF A COATING AND COMPOUND STRUCTURE CONTAINING SAID COATING | BASF COATINGS GMBH (DE) | 2025-06-05 | — | — | US | disclosed |
| US-4552830-A | UNSATURATED COMPOUND, FREE RADICAL-PRODUCING PHOTOINITIATOR FLUORA COLOR FORMER, PROTON DONOR | DYNACHEM CORPORATION (US) | 1985-11-12 | — | — | US | disclosed |
| US-4343885-A | PHOTORESISTS | DYNACHEM CORPORATION (US) | 1982-08-10 | — | — | US | disclosed |
| EP-0005380-B1 | PHOTOTROPIC PHOTOSENSITIVE COMPOSITIONS CONTAINING A FLUORAN COLORFORMER | Dynachem Corporation (US) | 1982-01-06 | — | — | EP | disclosed |
| EP-0005379-B1 | PHOTOSENSITIVE COMPOSITIONS CONTAINING CARBONYLIC HALIDES AS ACTIVATORS | Dynachem Corporation (US) | 1981-12-23 | — | — | EP | disclosed |
| EP-0005380-A2 | Phototropic photosensitive compositions containing a fluoran colorformer | Dynachem Corporation (US) | 1979-11-14 | — | — | EP | disclosed |
| EP-0005379-A2 | Photosensitive compositions containing carbonylic halides as activators | Dynachem Corporation (US) | 1979-11-14 | — | — | EP | disclosed |
| US-4102839-A | METAL SALT OF A CARBOXYLIC ACID AND A DIKETONE OR KETO-ALDEHYDE | RHONE-POULENC INDUSTRIES (FR) | 1978-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559631-B2 | Thermally curable two-component coating compounds | ESD, MGMT, MTHFD2 | AKR1C3 404/4885AKR1C2 406/4885MAPT 1446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.